

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.66288394 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.59942754 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.43024931 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.02169423 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.92399157 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.91682814 |
| 7 | vocalization behavior (GO:0071625) | 4.79234180 |
| 8 | neuronal action potential propagation (GO:0019227) | 4.78603171 |
| 9 | glutamate secretion (GO:0014047) | 4.78238921 |
| 10 | cerebellar granule cell differentiation (GO:0021707) | 4.75200696 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.64894990 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.55457172 |
| 13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.51600220 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.49517490 |
| 15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.43748378 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 4.40853582 |
| 17 | amino acid import (GO:0043090) | 4.36833546 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.27763972 |
| 19 | sodium ion export (GO:0071436) | 4.22233238 |
| 20 | cellular potassium ion homeostasis (GO:0030007) | 4.21871187 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.15254960 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.15002577 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.02387197 |
| 24 | cell communication by electrical coupling (GO:0010644) | 4.01180233 |
| 25 | exploration behavior (GO:0035640) | 3.96644729 |
| 26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.96493939 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.95973787 |
| 28 | protein localization to synapse (GO:0035418) | 3.86629376 |
| 29 | axon ensheathment in central nervous system (GO:0032291) | 3.78377587 |
| 30 | central nervous system myelination (GO:0022010) | 3.78377587 |
| 31 | activation of protein kinase A activity (GO:0034199) | 3.74969993 |
| 32 | positive regulation of dendritic spine development (GO:0060999) | 3.74764828 |
| 33 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.72244333 |
| 34 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.70797117 |
| 35 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.70524933 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 3.60869795 |
| 37 | potassium ion import (GO:0010107) | 3.59885273 |
| 38 | long-term memory (GO:0007616) | 3.58925574 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.58877111 |
| 40 | regulation of synapse maturation (GO:0090128) | 3.58145650 |
| 41 | neuromuscular process controlling posture (GO:0050884) | 3.57525925 |
| 42 | gamma-aminobutyric acid transport (GO:0015812) | 3.56486712 |
| 43 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.56484658 |
| 44 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.55691359 |
| 45 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.55579395 |
| 46 | glutamate receptor signaling pathway (GO:0007215) | 3.53083452 |
| 47 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.50464648 |
| 48 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.50343403 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.49865260 |
| 50 | proline transport (GO:0015824) | 3.49812177 |
| 51 | membrane depolarization during action potential (GO:0086010) | 3.49538219 |
| 52 | neuron-neuron synaptic transmission (GO:0007270) | 3.47045045 |
| 53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.45273343 |
| 54 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.45120589 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.44388550 |
| 56 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.41634783 |
| 57 | postsynaptic membrane organization (GO:0001941) | 3.41102486 |
| 58 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.40096954 |
| 59 | cell communication involved in cardiac conduction (GO:0086065) | 3.39159134 |
| 60 | dendritic spine morphogenesis (GO:0060997) | 3.38741128 |
| 61 | regulation of vesicle fusion (GO:0031338) | 3.37044017 |
| 62 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.35409674 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 3.35263556 |
| 64 | neurotransmitter transport (GO:0006836) | 3.31486756 |
| 65 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.28285068 |
| 66 | positive regulation of membrane potential (GO:0045838) | 3.28050963 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.27001026 |
| 68 | regulation of membrane repolarization (GO:0060306) | 3.26279979 |
| 69 | neuron cell-cell adhesion (GO:0007158) | 3.24826502 |
| 70 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.21318764 |
| 71 | glycine transport (GO:0015816) | 3.20924086 |
| 72 | regulation of synaptic plasticity (GO:0048167) | 3.19957462 |
| 73 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.18273850 |
| 74 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.18132261 |
| 75 | regulation of dendritic spine development (GO:0060998) | 3.17441886 |
| 76 | plasma membrane repair (GO:0001778) | 3.15963126 |
| 77 | dendritic spine organization (GO:0097061) | 3.12652905 |
| 78 | acidic amino acid transport (GO:0015800) | 3.12089566 |
| 79 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.11438585 |
| 80 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.11438585 |
| 81 | regulation of neurotransmitter levels (GO:0001505) | 3.09243068 |
| 82 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08649229 |
| 83 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.07409845 |
| 84 | neurotransmitter uptake (GO:0001504) | 3.05428756 |
| 85 | synaptic vesicle endocytosis (GO:0048488) | 3.05178309 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 3.04822689 |
| 87 | prepulse inhibition (GO:0060134) | 3.04226808 |
| 88 | membrane depolarization (GO:0051899) | 3.03954489 |
| 89 | potassium ion homeostasis (GO:0055075) | 3.02965921 |
| 90 | chemosensory behavior (GO:0007635) | 3.02364984 |
| 91 | positive regulation of synapse maturation (GO:0090129) | 3.01676354 |
| 92 | regulation of synaptic transmission (GO:0050804) | 2.98437732 |
| 93 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.95619549 |
| 94 | long-term synaptic potentiation (GO:0060291) | 2.94810440 |
| 95 | regulation of cell communication by electrical coupling (GO:0010649) | 2.94723171 |
| 96 | vesicle docking involved in exocytosis (GO:0006904) | 2.94193128 |
| 97 | regulation of ARF protein signal transduction (GO:0032012) | 2.94086738 |
| 98 | detection of calcium ion (GO:0005513) | 2.93845014 |
| 99 | positive regulation of potassium ion transport (GO:0043268) | 2.93367868 |
| 100 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.93220755 |
| 101 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.92942305 |
| 102 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.92505133 |
| 103 | membrane repolarization (GO:0086009) | 2.91305153 |
| 104 | cerebellar Purkinje cell layer development (GO:0021680) | 2.90493653 |
| 105 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.90226804 |
| 106 | transmission of nerve impulse (GO:0019226) | 2.89973025 |
| 107 | cellular sodium ion homeostasis (GO:0006883) | 2.89911852 |
| 108 | membrane hyperpolarization (GO:0060081) | 2.89206990 |
| 109 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.88886612 |
| 110 | vesicle transport along microtubule (GO:0047496) | 2.87363122 |
| 111 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.86924208 |
| 112 | positive regulation of dendrite development (GO:1900006) | 2.86776223 |
| 113 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86679632 |
| 114 | neuronal ion channel clustering (GO:0045161) | 2.85411154 |
| 115 | regulation of neurotransmitter transport (GO:0051588) | 2.85390010 |
| 116 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84857722 |
| 117 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.83867008 |
| 118 | positive regulation of neurotransmitter transport (GO:0051590) | 2.82968706 |
| 119 | striatum development (GO:0021756) | 2.82320476 |
| 120 | neuromuscular process (GO:0050905) | 2.82030286 |
| 121 | L-amino acid import (GO:0043092) | 2.80885979 |
| 122 | cell differentiation in hindbrain (GO:0021533) | 2.80853958 |
| 123 | auditory behavior (GO:0031223) | 2.78128781 |
| 124 | establishment of synaptic vesicle localization (GO:0097480) | 2.77162948 |
| 125 | synaptic vesicle transport (GO:0048489) | 2.77162948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.72961982 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03758955 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99503207 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84190107 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.77849193 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.75968592 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73765458 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73765458 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.72042514 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55402341 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54537144 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.53024930 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47511906 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42878821 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41593655 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31390264 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.26549810 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21512220 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18771293 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18554100 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18510833 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.15085490 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08400306 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.08374597 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00480627 |
| 26 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.82082156 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76198575 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65222054 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.63248837 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59689972 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56198515 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.47747753 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45373403 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43742776 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40937484 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40270772 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39253260 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39212589 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36950344 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34307708 |
| 41 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32927751 |
| 42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30692151 |
| 43 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30463461 |
| 44 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30054667 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28912685 |
| 46 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26802652 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26190983 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24633359 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23456371 |
| 50 | AR_19668381_ChIP-Seq_PC3_Human | 1.23041327 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20454580 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20211427 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19904086 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19650230 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19638333 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19583096 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18650995 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17289578 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14325080 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13930514 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13783302 |
| 62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12372579 |
| 63 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.11487257 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11406720 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08517458 |
| 66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07988370 |
| 67 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.06149550 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04815135 |
| 69 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03355953 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03267823 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03153501 |
| 72 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02156673 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02117210 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01699859 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01435089 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01282394 |
| 77 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01012760 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99612961 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99362718 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98706091 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97068454 |
| 82 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96343656 |
| 83 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95892658 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95760989 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95288470 |
| 86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95263449 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95221074 |
| 88 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95093365 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94834500 |
| 90 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94639543 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94054027 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93974744 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93901075 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93147282 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92128800 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91696084 |
| 97 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91339565 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90907368 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90712186 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90368371 |
| 101 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89970370 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89324969 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89294977 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89268638 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88462216 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87987316 |
| 107 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86988013 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86774184 |
| 109 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85823133 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85085662 |
| 111 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84871001 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84315087 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84311999 |
| 114 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83702994 |
| 115 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83579948 |
| 116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83060428 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82348024 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82207412 |
| 119 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81956669 |
| 120 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81695273 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79951554 |
| 122 | P68_20966046_ChIP-Seq_HELA_Human | 0.79732244 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.77010418 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76552349 |
| 125 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76512783 |
| 126 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.74698642 |
| 127 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74097713 |
| 128 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.73652537 |
| 129 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.72739171 |
| 130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70874688 |
| 131 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.70685634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.27057512 |
| 2 | MP0003880_abnormal_central_pattern | 4.12800243 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.82672785 |
| 4 | MP0004270_analgesia | 3.41253808 |
| 5 | MP0009046_muscle_twitch | 3.12913286 |
| 6 | MP0009745_abnormal_behavioral_response | 3.12509078 |
| 7 | MP0002064_seizures | 2.97126572 |
| 8 | MP0002822_catalepsy | 2.96713559 |
| 9 | * MP0002063_abnormal_learning/memory/cond | 2.92324076 |
| 10 | MP0000751_myopathy | 2.74639647 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.73002538 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.72384671 |
| 13 | MP0002272_abnormal_nervous_system | 2.55398521 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.43507433 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.35517540 |
| 16 | MP0003646_muscle_fatigue | 2.31915158 |
| 17 | MP0001486_abnormal_startle_reflex | 2.29221723 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.27889495 |
| 19 | MP0008569_lethality_at_weaning | 2.21080903 |
| 20 | MP0004215_abnormal_myocardial_fiber | 2.06953709 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.06843233 |
| 22 | MP0002736_abnormal_nociception_after | 2.04436670 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.03111007 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.99262366 |
| 25 | MP0004858_abnormal_nervous_system | 1.95057550 |
| 26 | MP0001440_abnormal_grooming_behavior | 1.85709314 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.84980294 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.80640913 |
| 29 | MP0001970_abnormal_pain_threshold | 1.80398811 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.77159756 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.74982198 |
| 32 | MP0003329_amyloid_beta_deposits | 1.74927100 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.70178098 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.63973244 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.63540394 |
| 36 | MP0004924_abnormal_behavior | 1.63540394 |
| 37 | * MP0004811_abnormal_neuron_physiology | 1.55083297 |
| 38 | MP0000749_muscle_degeneration | 1.51935454 |
| 39 | MP0002184_abnormal_innervation | 1.49449861 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.44052156 |
| 41 | MP0004484_altered_response_of | 1.38651464 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.37517824 |
| 43 | MP0000955_abnormal_spinal_cord | 1.35668465 |
| 44 | MP0004085_abnormal_heartbeat | 1.35418892 |
| 45 | MP0003879_abnormal_hair_cell | 1.31894558 |
| 46 | * MP0002066_abnormal_motor_capabilities/c | 1.31875695 |
| 47 | * MP0003633_abnormal_nervous_system | 1.31318309 |
| 48 | MP0004233_abnormal_muscle_weight | 1.30931529 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.28299128 |
| 50 | MP0004130_abnormal_muscle_cell | 1.25126694 |
| 51 | MP0004885_abnormal_endolymph | 1.23467419 |
| 52 | MP0000747_muscle_weakness | 1.22787887 |
| 53 | * MP0002882_abnormal_neuron_morphology | 1.19809399 |
| 54 | MP0004142_abnormal_muscle_tone | 1.19281801 |
| 55 | MP0005330_cardiomyopathy | 1.18622194 |
| 56 | MP0005620_abnormal_muscle_contractility | 1.18122385 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.17741126 |
| 58 | MP0001984_abnormal_olfaction | 1.15834017 |
| 59 | MP0004087_abnormal_muscle_fiber | 1.15760925 |
| 60 | MP0004510_myositis | 1.13636893 |
| 61 | MP0000579_abnormal_nail_morphology | 1.12813710 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.12321110 |
| 63 | MP0002972_abnormal_cardiac_muscle | 1.10827127 |
| 64 | MP0003123_paternal_imprinting | 1.09649896 |
| 65 | * MP0003631_nervous_system_phenotype | 1.06598269 |
| 66 | * MP0000778_abnormal_nervous_system | 1.05815836 |
| 67 | MP0008874_decreased_physiological_sensi | 1.03536319 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.02586823 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.01378320 |
| 70 | MP0002269_muscular_atrophy | 0.99416409 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.99140464 |
| 72 | MP0004742_abnormal_vestibular_system | 0.96315990 |
| 73 | MP0003075_altered_response_to | 0.96111500 |
| 74 | MP0005409_darkened_coat_color | 0.94643549 |
| 75 | MP0002106_abnormal_muscle_physiology | 0.94391092 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.94333373 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 0.91488711 |
| 78 | MP0008775_abnormal_heart_ventricle | 0.91424572 |
| 79 | MP0001963_abnormal_hearing_physiology | 0.90586635 |
| 80 | MP0000759_abnormal_skeletal_muscle | 0.90389458 |
| 81 | MP0003690_abnormal_glial_cell | 0.89793643 |
| 82 | MP0001529_abnormal_vocalization | 0.89416470 |
| 83 | MP0003283_abnormal_digestive_organ | 0.89359318 |
| 84 | * MP0002229_neurodegeneration | 0.89246033 |
| 85 | MP0008872_abnormal_physiological_respon | 0.88546804 |
| 86 | MP0005535_abnormal_body_temperature | 0.88541311 |
| 87 | MP0000920_abnormal_myelination | 0.85053809 |
| 88 | MP0005369_muscle_phenotype | 0.84394221 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.84204710 |
| 90 | MP0001905_abnormal_dopamine_level | 0.83228990 |
| 91 | * MP0002152_abnormal_brain_morphology | 0.83040232 |
| 92 | MP0003787_abnormal_imprinting | 0.82687011 |
| 93 | MP0003122_maternal_imprinting | 0.82318616 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.80051205 |
| 95 | MP0003634_abnormal_glial_cell | 0.79751122 |
| 96 | MP0006138_congestive_heart_failure | 0.77792273 |
| 97 | MP0001958_emphysema | 0.75692341 |
| 98 | MP0002090_abnormal_vision | 0.75355722 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.74623351 |
| 100 | MP0001177_atelectasis | 0.74421515 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.73033393 |
| 102 | MP0005645_abnormal_hypothalamus_physiol | 0.72221211 |
| 103 | MP0003632_abnormal_nervous_system | 0.71642788 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.71625709 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.71247381 |
| 106 | MP0001544_abnormal_cardiovascular_syste | 0.70823324 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.70823324 |
| 108 | MP0004043_abnormal_pH_regulation | 0.70026846 |
| 109 | MP0000604_amyloidosis | 0.69121122 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.68771618 |
| 111 | MP0005166_decreased_susceptibility_to | 0.64707077 |
| 112 | MP0003045_fibrosis | 0.63489289 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.63265765 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.62774281 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.61508394 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.60293038 |
| 117 | MP0005275_abnormal_skin_tensile | 0.59819472 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.59222133 |
| 119 | MP0002249_abnormal_larynx_morphology | 0.57190698 |
| 120 | MP0004147_increased_porphyrin_level | 0.57078119 |
| 121 | MP0002133_abnormal_respiratory_system | 0.55067460 |
| 122 | MP0005388_respiratory_system_phenotype | 0.55067460 |
| 123 | MP0001986_abnormal_taste_sensitivity | 0.51185701 |
| 124 | MP0005165_increased_susceptibility_to | 0.50978462 |
| 125 | MP0010769_abnormal_survival | 0.49013748 |
| 126 | MP0005670_abnormal_white_adipose | 0.45376530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.84532768 |
| 2 | Myokymia (HP:0002411) | 6.59599089 |
| 3 | Focal seizures (HP:0007359) | 5.08155282 |
| 4 | Visual hallucinations (HP:0002367) | 4.79297607 |
| 5 | Action tremor (HP:0002345) | 4.38910212 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.28191744 |
| 7 | Atonic seizures (HP:0010819) | 4.19230140 |
| 8 | Obstructive sleep apnea (HP:0002870) | 4.12399463 |
| 9 | Ventricular fibrillation (HP:0001663) | 3.98563431 |
| 10 | Febrile seizures (HP:0002373) | 3.97683871 |
| 11 | Sudden death (HP:0001699) | 3.86337292 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.83463649 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.75440122 |
| 14 | Bundle branch block (HP:0011710) | 3.73024095 |
| 15 | Absence seizures (HP:0002121) | 3.72035237 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.55695336 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.50884831 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.45048080 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.30904131 |
| 20 | Dialeptic seizures (HP:0011146) | 3.30769244 |
| 21 | Tetraplegia (HP:0002445) | 3.28692087 |
| 22 | Dysmetric saccades (HP:0000641) | 3.27857308 |
| 23 | Depression (HP:0000716) | 3.17678702 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.14182478 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 3.13801584 |
| 26 | Ankle clonus (HP:0011448) | 3.12132136 |
| 27 | Poor eye contact (HP:0000817) | 3.10345786 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.07913441 |
| 29 | Prolonged QT interval (HP:0001657) | 3.00886734 |
| 30 | Postural instability (HP:0002172) | 2.98657336 |
| 31 | Broad-based gait (HP:0002136) | 2.96859047 |
| 32 | Dysmetria (HP:0001310) | 2.95904613 |
| 33 | Impaired social interactions (HP:0000735) | 2.95765855 |
| 34 | Abnormal social behavior (HP:0012433) | 2.95765855 |
| 35 | Atrial fibrillation (HP:0005110) | 2.92840713 |
| 36 | Anxiety (HP:0000739) | 2.92033669 |
| 37 | Cerebral hypomyelination (HP:0006808) | 2.88879896 |
| 38 | Syncope (HP:0001279) | 2.88243113 |
| 39 | Calf muscle hypertrophy (HP:0008981) | 2.87691483 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86323257 |
| 41 | Primary atrial arrhythmia (HP:0001692) | 2.84968462 |
| 42 | Truncal ataxia (HP:0002078) | 2.81697798 |
| 43 | Neuronal loss in central nervous system (HP:0002529) | 2.81199144 |
| 44 | Pheochromocytoma (HP:0002666) | 2.79776415 |
| 45 | Exercise-induced muscle cramps (HP:0003710) | 2.78742876 |
| 46 | Abnormal EKG (HP:0003115) | 2.77807002 |
| 47 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.75977560 |
| 48 | Delusions (HP:0000746) | 2.75245225 |
| 49 | Urinary urgency (HP:0000012) | 2.71000047 |
| 50 | Supraventricular tachycardia (HP:0004755) | 2.69110851 |
| 51 | Myotonia (HP:0002486) | 2.68065841 |
| 52 | Supraventricular arrhythmia (HP:0005115) | 2.61732473 |
| 53 | Annular pancreas (HP:0001734) | 2.60903363 |
| 54 | Scanning speech (HP:0002168) | 2.60056577 |
| 55 | Heart block (HP:0012722) | 2.58915210 |
| 56 | Hemiplegia (HP:0002301) | 2.57524069 |
| 57 | Limb dystonia (HP:0002451) | 2.54758025 |
| 58 | Abnormality of the calf musculature (HP:0001430) | 2.53174694 |
| 59 | Abnormality of the lower motor neuron (HP:0002366) | 2.52991565 |
| 60 | Sleep apnea (HP:0010535) | 2.50999429 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.48449344 |
| 62 | Apathy (HP:0000741) | 2.48287888 |
| 63 | Intention tremor (HP:0002080) | 2.48235322 |
| 64 | Akinesia (HP:0002304) | 2.47702986 |
| 65 | Clonus (HP:0002169) | 2.46374929 |
| 66 | Ventricular arrhythmia (HP:0004308) | 2.45210687 |
| 67 | Rigidity (HP:0002063) | 2.44124943 |
| 68 | Peripheral hypomyelination (HP:0007182) | 2.42213053 |
| 69 | Impaired smooth pursuit (HP:0007772) | 2.41830608 |
| 70 | Genetic anticipation (HP:0003743) | 2.40788354 |
| 71 | Neuroendocrine neoplasm (HP:0100634) | 2.39635843 |
| 72 | Abnormal atrioventricular conduction (HP:0005150) | 2.39036763 |
| 73 | Hyporeflexia of lower limbs (HP:0002600) | 2.36545054 |
| 74 | Papilledema (HP:0001085) | 2.34269495 |
| 75 | Difficulty running (HP:0009046) | 2.33634674 |
| 76 | Amblyopia (HP:0000646) | 2.29872829 |
| 77 | Termporal pattern (HP:0011008) | 2.28430305 |
| 78 | Insidious onset (HP:0003587) | 2.28430305 |
| 79 | Torticollis (HP:0000473) | 2.27905782 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.24190110 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.22108258 |
| 82 | Aplasia of the phalanges of the hand (HP:0009802) | 2.21567046 |
| 83 | Aplasia involving bones of the extremities (HP:0009825) | 2.21567046 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.21567046 |
| 85 | Rapidly progressive (HP:0003678) | 2.20756008 |
| 86 | Diminished motivation (HP:0000745) | 2.19758938 |
| 87 | Resting tremor (HP:0002322) | 2.18942564 |
| 88 | Atrioventricular block (HP:0001678) | 2.18872085 |
| 89 | Bradykinesia (HP:0002067) | 2.16835187 |
| 90 | Spastic gait (HP:0002064) | 2.16802964 |
| 91 | Fetal akinesia sequence (HP:0001989) | 2.16004032 |
| 92 | EMG: myopathic abnormalities (HP:0003458) | 2.14686703 |
| 93 | Hyperventilation (HP:0002883) | 2.11747360 |
| 94 | Progressive inability to walk (HP:0002505) | 2.10240660 |
| 95 | Status epilepticus (HP:0002133) | 2.09941511 |
| 96 | Impaired vibratory sensation (HP:0002495) | 2.08938289 |
| 97 | Focal dystonia (HP:0004373) | 2.08801584 |
| 98 | Mutism (HP:0002300) | 2.07907768 |
| 99 | Hemiparesis (HP:0001269) | 2.07630691 |
| 100 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.07562044 |
| 101 | Increased circulating renin level (HP:0000848) | 2.04807627 |
| 102 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03076055 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 2.02615900 |
| 104 | Central scotoma (HP:0000603) | 2.02483433 |
| 105 | Lower limb muscle weakness (HP:0007340) | 2.00238325 |
| 106 | Muscle fiber splitting (HP:0003555) | 1.99513728 |
| 107 | Spinal canal stenosis (HP:0003416) | 1.98991708 |
| 108 | Distal upper limb amyotrophy (HP:0007149) | 1.98692942 |
| 109 | Upper limb amyotrophy (HP:0009129) | 1.98692942 |
| 110 | Megalencephaly (HP:0001355) | 1.98006444 |
| 111 | Spastic tetraparesis (HP:0001285) | 1.97710946 |
| 112 | Stereotypic behavior (HP:0000733) | 1.97462318 |
| 113 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.97062736 |
| 114 | Myoglobinuria (HP:0002913) | 1.95804126 |
| 115 | Pointed chin (HP:0000307) | 1.95516846 |
| 116 | Bronchomalacia (HP:0002780) | 1.95101857 |
| 117 | Turricephaly (HP:0000262) | 1.91901328 |
| 118 | Abnormality of saccadic eye movements (HP:0000570) | 1.91565945 |
| 119 | Diplopia (HP:0000651) | 1.89705346 |
| 120 | Abnormality of binocular vision (HP:0011514) | 1.89705346 |
| 121 | Incomplete penetrance (HP:0003829) | 1.88654631 |
| 122 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88642691 |
| 123 | Choreoathetosis (HP:0001266) | 1.85575562 |
| 124 | Craniofacial dystonia (HP:0012179) | 1.84227766 |
| 125 | Slow progression (HP:0003677) | 1.83592445 |
| 126 | Ventricular tachycardia (HP:0004756) | 1.82589420 |
| 127 | Lower limb asymmetry (HP:0100559) | 1.81790357 |
| 128 | Abnormality of the foot musculature (HP:0001436) | 1.80525938 |
| 129 | Insomnia (HP:0100785) | 1.78792659 |
| 130 | Foot dorsiflexor weakness (HP:0009027) | 1.77866833 |
| 131 | Gait ataxia (HP:0002066) | 1.76386359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.06584731 |
| 2 | EPHA4 | 3.84027925 |
| 3 | MAP3K9 | 3.57600166 |
| 4 | MAP3K4 | 2.75889696 |
| 5 | MINK1 | 2.54589144 |
| 6 | PAK6 | 2.34013518 |
| 7 | DAPK2 | 2.30145665 |
| 8 | PRKD3 | 2.28346954 |
| 9 | KSR2 | 2.23786698 |
| 10 | LMTK2 | 2.23724802 |
| 11 | CAMKK1 | 2.13138815 |
| 12 | PHKG2 | 2.03766153 |
| 13 | PHKG1 | 2.03766153 |
| 14 | MAP2K7 | 1.96170350 |
| 15 | MAP2K4 | 1.89986346 |
| 16 | STK38 | 1.84479540 |
| 17 | NTRK1 | 1.83128048 |
| 18 | RIPK4 | 1.79613770 |
| 19 | PINK1 | 1.74855092 |
| 20 | NTRK2 | 1.64710134 |
| 21 | MARK1 | 1.63914046 |
| 22 | MAP3K12 | 1.60455694 |
| 23 | CDK5 | 1.40141682 |
| 24 | CAMKK2 | 1.36043333 |
| 25 | DAPK1 | 1.30755342 |
| 26 | NEK1 | 1.26533458 |
| 27 | CDK19 | 1.21402137 |
| 28 | KSR1 | 1.20129053 |
| 29 | GRK5 | 1.16684587 |
| 30 | RIPK1 | 1.15440397 |
| 31 | TYRO3 | 1.11909709 |
| 32 | PRPF4B | 1.10708868 |
| 33 | DMPK | 1.10260621 |
| 34 | ARAF | 1.10214645 |
| 35 | TAOK1 | 1.09873207 |
| 36 | NEK6 | 1.08843388 |
| 37 | WNK1 | 1.08796161 |
| 38 | PRKCH | 1.07897838 |
| 39 | MAP3K2 | 1.07519353 |
| 40 | CAMK1 | 1.06457260 |
| 41 | LATS2 | 1.05411720 |
| 42 | PRKCG | 1.03628549 |
| 43 | UHMK1 | 1.03549010 |
| 44 | TTN | 0.98175117 |
| 45 | FES | 0.98034939 |
| 46 | PDK3 | 0.97831661 |
| 47 | PDK4 | 0.97831661 |
| 48 | PAK3 | 0.96757538 |
| 49 | MAP3K13 | 0.96074958 |
| 50 | CAMK2A | 0.95929430 |
| 51 | RET | 0.95822296 |
| 52 | SIK2 | 0.95324531 |
| 53 | SGK494 | 0.94111607 |
| 54 | SGK223 | 0.94111607 |
| 55 | PLK2 | 0.93418377 |
| 56 | STK11 | 0.91710807 |
| 57 | TRIB3 | 0.91678326 |
| 58 | SGK3 | 0.91471370 |
| 59 | PDK1 | 0.85488701 |
| 60 | MAP3K7 | 0.85457187 |
| 61 | SGK2 | 0.82863127 |
| 62 | TNIK | 0.82474838 |
| 63 | CDC42BPA | 0.82258838 |
| 64 | PDPK1 | 0.82246136 |
| 65 | DYRK1A | 0.81428581 |
| 66 | OBSCN | 0.80826242 |
| 67 | PTK2B | 0.79586994 |
| 68 | LIMK1 | 0.78030948 |
| 69 | ALK | 0.77587255 |
| 70 | PNCK | 0.75701673 |
| 71 | TESK1 | 0.75648424 |
| 72 | CAMK2D | 0.72713640 |
| 73 | MAP3K11 | 0.72316834 |
| 74 | MAP3K1 | 0.71423533 |
| 75 | CDK15 | 0.71243240 |
| 76 | CDK18 | 0.70670418 |
| 77 | PKN1 | 0.69473765 |
| 78 | MAPK13 | 0.68748308 |
| 79 | SGK1 | 0.68220422 |
| 80 | CAMK4 | 0.66022482 |
| 81 | CDK14 | 0.65669115 |
| 82 | CAMK2B | 0.65475136 |
| 83 | TNK2 | 0.65469825 |
| 84 | RAF1 | 0.65045189 |
| 85 | MUSK | 0.64216996 |
| 86 | BRSK1 | 0.63828984 |
| 87 | BMPR2 | 0.61050375 |
| 88 | CAMK2G | 0.60442711 |
| 89 | CDK11A | 0.60180496 |
| 90 | BRAF | 0.59741616 |
| 91 | CAMK1G | 0.56396917 |
| 92 | CASK | 0.55783395 |
| 93 | OXSR1 | 0.53774429 |
| 94 | DAPK3 | 0.53498817 |
| 95 | RPS6KA3 | 0.53262561 |
| 96 | ROCK2 | 0.53170989 |
| 97 | MARK2 | 0.52259348 |
| 98 | FER | 0.50801934 |
| 99 | PRKD1 | 0.50055089 |
| 100 | MAP2K1 | 0.49274852 |
| 101 | PDGFRA | 0.48588342 |
| 102 | ROCK1 | 0.47551446 |
| 103 | MYLK | 0.46514592 |
| 104 | PRKG2 | 0.45532835 |
| 105 | NME1 | 0.44747116 |
| 106 | PRKCE | 0.44084489 |
| 107 | MAPK12 | 0.42641067 |
| 108 | MAPK10 | 0.42330343 |
| 109 | FYN | 0.42243541 |
| 110 | PDK2 | 0.40892825 |
| 111 | ICK | 0.40814192 |
| 112 | MAP2K6 | 0.40455397 |
| 113 | DDR2 | 0.40418890 |
| 114 | MOS | 0.40412446 |
| 115 | FGFR2 | 0.39294594 |
| 116 | MAPK4 | 0.36225765 |
| 117 | MAPK7 | 0.35806319 |
| 118 | PRKCZ | 0.33934222 |
| 119 | PRKCA | 0.32318112 |
| 120 | JAK1 | 0.31014618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.02756082 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.92343083 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63208511 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.47906728 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.42838646 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39046776 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.31304569 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28362035 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.24551611 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.20847737 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11835277 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.08099638 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.99434042 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.98772891 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93166947 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88289004 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85380612 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.78163403 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.77938123 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69163961 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67625321 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.62642280 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.60410092 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58438394 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.55376767 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.51409813 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46733895 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45273173 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44262438 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.43290989 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40723208 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.34828207 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28609316 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27824906 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.27491211 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25243619 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24582464 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24548855 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22527298 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16621941 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16563805 |
| 42 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.09220610 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08715377 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.07784727 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02061986 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98584481 |
| 47 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95022296 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92959832 |
| 49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92820235 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.90167381 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89666248 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88017041 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87573472 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84526177 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80185035 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77995973 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75985491 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75067555 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72403220 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72345883 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.71305179 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.69547113 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69271080 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68807087 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67903910 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67226454 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64850012 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63256811 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63073535 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62916912 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62875616 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62661641 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61807288 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61300453 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.60053378 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59650908 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58077620 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57818417 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55850966 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54173279 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53398424 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53201301 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51873624 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.49253161 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48964648 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46928898 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46446135 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45235178 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44087068 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43865038 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42683337 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39672438 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39126803 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.39113653 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38427671 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37665705 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37527634 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36757005 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35541975 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35171289 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34600846 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34093715 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34067128 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.31298185 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31230461 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31013386 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.30746444 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.30404195 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28869799 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.28593443 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28046266 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.27188830 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.25668383 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24642956 |

